Publications by authors named "D Gruener"

Claim this Profile
P
Proof-of-Mechanism Study of the Phosphodiesterase 10 Inhibitor RG7203 in Patients With Schizophrenia and Negative Symptoms.
Daniel Umbricht, Markus Abt, Paul Tamburri, Christopher Chatham, Štefan Holiga, Daniel Gruener

Biol Psychiatry Glob Open Sci· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, pharmacokinetics and pharmacodynamics of the oral toll-like receptor 7 agonist GS-9620 in treatment-naive patients with chronic hepatitis C.
Eric Lawitz, Daniel Gruener, Thomas Marbury, John Hill, Lynn Webster

Antivir Ther· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Tolerability of Switching Patients on Chronic Full μ-Opioid Agonist Therapy to Buccal Buprenorphine.
Lynn Webster, Daniel Gruener, Todd Kirby, Qinfang Xiang, Evan Tzanis

Pain Med· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, multiple-dose study of the pan-genotypic NS5A inhibitor samatasvir in patients infected with hepatitis C virus genotype 1, 2, 3 or 4.
Bradley Vince, John M Hill, Eric J Lawitz, William O'Riordan, Lynn R Webster, Daniel M Gruener

J Hepatol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes from an open-label study of edivoxetine use in pediatric patients with attention-deficit/hyperactivity disorder.
Ling Jin, Wen Xu, David Krefetz, Daniel Gruener, William Kielbasa

J Child Adolesc Psychopharmacol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis